Stay updated on First-Line Tarlatamab Combo in ES-SCLC Clinical Trial

Sign up to get notified when there's something new on the First-Line Tarlatamab Combo in ES-SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the First-Line Tarlatamab Combo in ES-SCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.2; revision v3.5.0 was removed.
    Difference
    0.0%
    Check dated 2026-04-17T02:48:43.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 is displayed on the page. This change reflects a minor version update with no apparent impact on content or user actions.
    Difference
    0.0%
    Check dated 2026-03-19T06:19:24.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T00:29:20.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    New date stamps and results-posting status were added (e.g., 'No Results Posted' on 2026-03-03), and older entries were removed. The overall study details, eligibility criteria, and planned interventions remain unchanged.
    Difference
    0.2%
    Check dated 2026-03-05T00:22:09.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    - Revision: v3.4.2 has been added. The government funding notice and Revision: v3.4.1 banner have been removed; no study content or eligibility information was changed.
    Difference
    0.3%
    Check dated 2026-02-11T12:41:16.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Results status updated from No Results Posted to Results Submitted, and the page revision shows Revision: v3.4.1. A government-funding status notice about NIH operations is also displayed.
    Difference
    0.3%
    Check dated 2026-02-04T10:11:58.000Z thumbnail image

Stay in the know with updates to First-Line Tarlatamab Combo in ES-SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the First-Line Tarlatamab Combo in ES-SCLC Clinical Trial page.